No Result

View All Result

No products in the cart.

Home StudyGraphics

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

byKathleen Lau

February 5, 2021

in StudyGraphics

RELATED REPORTS

Analysis of clinical outcomes utilizing ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism

Ivonescimab improves survival in advanced non-small cell lung cancer

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

RelatedReports

Quick Take: Hospital volume and outcomes for acute pulmonary embolism

Cardiology

Analysis of clinical outcomes utilizing ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism

April 30, 2025

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025

#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation

StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025

StudyGraphics

#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation

April 18, 2025

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind February 8, 2021

Quick Take: Association of Cereal, Gluten, and Dietary Fiber Intake With Islet Autoimmunity and Type 1 Diabetes

Higher consumption of refined grains other than white rice associated with a greater mortality and cardiovascular disease risk

Type I diabetes not associated with early menopause [OVADIA study]

Māori and Pacific New Zealanders may be disproportionately affected by type 2 diabetes-related clinical outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result